Thermo's new way to study proteomics
A new piece of equipment could enable scientists to study changes in protein structure, including those necessary to cancer tumour growth, both faster and more accurately, according to its developers.
Archives for March 16, 2007
Affymetrix wins round one against Illumina
The US District Court of Delaware returned a verdict in favour of Affymetrix in the first stage of its patent infringement case against Illumina.
Another setback for Lilly's blindness drug
Eli Lilly & Co has withdrawn its European approval application for Arxxant (ruboxistaurin), a potential blockbuster drug to treat blindness caused by diabetes.
GSK's new breast cancer drug approved
GlaxoSmithKline's (GSK) new breast cancer drug has been given the all clear to be used in the US, with the company expecting European approval to follow later this year.
Millipore licenses neural stem cells
A new licensing deal will allow Millipore to supply researchers with a commercial source of neural stem cells for the first time.